CORT
Corcept Therapeutics Inc Earnings
$72.01
Earnings Summary
Revenue | $157.21Mn |
Net Profits | $20.29Mn |
Net Profit Margins | 12.9% |
PE Ratio | 59.08 |
Corcept Therapeutics Inc’s revenue jumped 7.09% since last year same period to $157.21Mn in the Q1 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -13.57% fall in its revenue since last 3-months.
Corcept Therapeutics Inc’s net profit fell -26.92% since last year same period to $20.29Mn in the Q1 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -33.24% fall in its net profits since last 3-months.
Corcept Therapeutics Inc’s net profit margin fell -31.76% since last year same period to 12.9% in the Q1 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -22.76% fall in its net profit margins since last 3-months.
Corcept Therapeutics Inc’s price-to-earnings ratio after this Q1 2025 earnings stands at 59.08.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 0.41 |
EPS Estimate Current Year | 0.41 |
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.41 - a 117.81% jump from last quarter’s estimates.
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.41.
Key Ratios
Earning Per Share (EPS) | 0 |
Corcept Therapeutics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Corcept Therapeutics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-05 | 0.14 | 0.17 | 18.81% |
2025-10-29 | 0.41 | 0 | -100% |
